Vaxart (VXRT) Surges 25% on New Buy Rating

June 11, 2021 10:12 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Vaxart (NASDAQ: VXRT) gains 25% following today's new buy rating at Piper Sandler.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Momentum Movers, Trader Talk